Printer Friendly

Amersham Biosciences Introduces Tricorn High Performance Columns; Tricorn Columns Replace HR Columns as New Gold Standard for Protein Purification.

Business Editors/Health & Medical Writers

BIOWIRE2K

PISCATAWAY, N.J.--(BUSINESS WIRE)--Nov. 20, 2002

Amersham Biosciences, the life sciences business of Amersham plc (LSE:, NYSE:, OSE: AHM), has introduced Tricorn(TM) High Performance Columns designed for high resolution purification of proteins, peptides and other biomolecules.

The new Tricorn line replaces Amersham Biosciences' HR columns prepacked with media such as Superdex(TM) and MonoBeads(TM), long the gold standards for laboratory-scale protein separations.

The high resolution separation achievable with Tricorn columns make them ideal to get the final purity of a protein sample. This will enable scientists to isolate and purify individual proteins that may prove to be valuable new drug targets.

"The design of Tricorn provides simpler handling and direct connection to high performance systems such as AKTA(TM) design," says Allan Simpson, Vice-President Lab Separations Marketing at Amersham Biosciences. "Researchers in academia and the pharma and biotech industries will find that Tricorn columns are equal or superior to HR columns for performing high resolution, preparative liquid chromatography.

Tricorn columns are made of glass and PEEK and are available either empty or prepacked with a variety of chromatographic media, including Superdex for gel filtration, MonoBeads for ion exchange and chromatofocusing, and SOURCE(TM) for hydrophobic interaction and Ion Exchange.

More information about Tricorn is available at www.tricorncolumns.com

Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technology are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. More information about Amersham Biosciences is available at www.amershambiosciences.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 20, 2002
Words:314
Previous Article:Ericsson Adopts CompTIA CTT+.
Next Article:Eclipse Lands UK Supply of Anti-Theft Car Immobiliser.
Topics:


Related Articles
A balancing act for chemical purity.
Protein identified in dinosaur fossils.
Final rule--correction to amendment to Regulations H and Y. (Legal Developments).
Amersham Biosciences Creates Linnaeus Chair At Muhlenberg College.
Amersham Biosciences Launches Protein Purification System To Link Process Development and Large Scale Production.
Amersham Biosciences Simplifies DNA Preparation Process with Innovative Whole Genome Amplification Method.
HPLC testing columns.
Grapes lends his voice to church musical play.
Molecular mechanisms of West Nile virus pathogenesis in brain cells.
Periplaneta americana arginine kinase as a major cockroach allergen among Thai patients with major cockroach allergies.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters